As of August 2024, Sino Biopharmaceutical has a market cap of $7.76B. This makes Sino Biopharmaceutical the world's 1977th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $7.11B | -14.99% |
2023 | $8.37B | -24.07% |
2022 | $11.02B | -16.30% |
2021 | $13.17B | -27.68% |
2020 | $18.20B | 3.90% |
2019 | $17.52B | 111.24% |
2018 | $8.29B | -44.16% |
2017 | $14.85B | 153.85% |
2016 | $5.85B | -22.66% |
2015 | $7.57B | 50.64% |
2014 | $5.02B | 14.31% |
2013 | $4.39B | 66.22% |
2012 | $2.64B | 60.17% |
2011 | $1.65B | -20.07% |
2010 | $2.06B | 15.60% |
2009 | $1.79B | 376.21% |
2008 | $375.06M | -27.59% |
2007 | $517.97M | 57.61% |
2006 | $328.65M | -42.14% |
2005 | $567.98M | 50.95% |
2004 | $376.27M | - |